Company Overview and News

 
10 Dividend Growth Stocks For April 2018

2018-04-19 seekingalpha
Every month, I rank a selection of David Fish's CCC stocks and present the top 10 ranked stocks as candidates for further research.
Upvote Downvote

 
BRIEF-Aetna To Release Q1 2018 Results; Announces Business Segment Realignment

2018-04-17 reuters
* AETNA - EFFECTIVE FOR Q1, REALIGNED BUSINESS SEGMENTS TO CORRESPOND WITH CHANGES TO ITS MANAGEMENT STRUCTURE AND INTERNAL MANAGEMENT REPORTING
Upvote Downvote

1
AET / Aetna, Inc. 8-K (Current Report)

2018-04-17 sec.gov
Document UNITED STATES
Upvote Downvote

 
Aetna to Release First-Quarter 2018 Results; Announces Business Segment Realignment

2018-04-17 businesswire
HARTFORD, Conn.--(BUSINESS WIRE)--Aetna (NYSE: AET) today announced that first-quarter 2018 results will be made public on Tuesday, May 1, at 6:30 a.m. ET. Given the pending transaction with CVS Health, Aetna will not host a conference call in conjunction with its earnings release and does not expect to do so for future quarters.
Upvote Downvote

 
Goldman outpaces peers in debt underwriting, bond trading

2018-04-17 reuters
NEW YORK (Reuters) - Goldman Sachs Group Inc on Tuesday reported a year-on-year jump in debt underwriting revenue after working on financing for big M&A deals that some peers missed out on.
Upvote Downvote

 
UnitedHealth Group Inc Stock: Wall Street’s Biggest Moat

2018-04-17 investorplace
UnitedHealth Group Inc (NYSE:UNH), the giant health insurer, beat the street on April 17 and raised estimates, illustrating its dominance in the healthcare space.
Upvote Downvote

 
UnitedHealth earnings ease investor worries over flu season, stock up

2018-04-17 channelnewsasia
UnitedHealth Group Inc on Tuesday posted a quarterly profit that beat Wall Street estimates, fueled by growth in its core insurance and health-services businesses and raised its earnings forecast for the year.
Upvote Downvote

 
UnitedHealth profit beats and it raises 2018 outlook

2018-04-17 channelnewsasia
UnitedHealth Group Inc on Tuesday posted a quarterly profit that beat Wall Street estimates, fueled by growth in its core insurance and health-services businesses and raised its earnings forecast for the year.
Upvote Downvote

 
UnitedHealth profit beats on strong growth across businesses

2018-04-17 channelnewsasia
REUTERS: UnitedHealth Group Inc on Tuesday posted a quarterly profit that beat Wall Street estimates, fueled by growth in its core insurance and health-services businesses and raised its earnings forecast for the year.
Upvote Downvote

 
UnitedHealth profit beats on strong growth across businesses - Channel NewsAsia

2018-04-17 channelnewsasia
REUTERS: UnitedHealth Group Inc on Tuesday posted a quarterly profit that beat Wall Street estimates, fueled by growth in its core insurance and health-services businesses and raised its earnings forecast for the year.
Upvote Downvote

 
Fixing Drug Costs

2018-04-17 seekingalpha
Concerns that the U.S. government might negotiate drug prices have weighed on health care stocks since the 2016 presidential campaign.
Upvote Downvote

 
UnitedHealth (UNH) Q1 Earnings to Gain From Optum Revenues

2018-04-16 zacks
We believe UnitedHealth Group Inc.’s (UNH - Free Report) health services business Optum will be an important ingredient of its first-quarter earnings growth. Optum serves the global healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. The company is investing in this segment with an aim to diversify earnings and seek protection from the highly regulated health services business.
Upvote Downvote

 
Upcoming Dividends: 12 Companies, 3 Increases, 2 Double-Digit Increases

2018-04-13 seekingalpha
This is the list of dividend stocks from the popular U.S. Dividend Champion, Challenger, Contender ("CCC") list that is going ex-dividend next week.
Upvote Downvote

 
Upcoming Dividends: 12 Companies, 12 Increases, 6 Double-Digit Increases

2018-04-13 seekingalpha
This is the list of dividend stocks from the popular U.S. Dividend Champion, Challenger, Contender ("CCC") list that is going ex-dividend next week.
Upvote Downvote

 
Humana (HUM) Shores Up Government Business With FPG Buyout

2018-04-11 zacks
Humana Inc. (HUM - Free Report) has recently announced that it has completed the acquisition of Orlando, FL-based Family Physicians Group (“FPG”). Financial terms of the deal remain undisclosed.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 00817Y108